What is the size of the Primary Cells market in 2023?

The Primary Cells market size is USD 1.8 billion in 2023.

What is the projected CAGR at which the Primary Cells market is expected to grow at?

The Primary Cells market is expected to grow at a CAGR of 10.1% (2024-2033).

List the segments encompassed in this report on the Primary Cells market?

Market.US has segmented the Primary Cells market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Source the market has been segmented into Hematopoietic Cells, Lung Cells, Gastrointestinal Cells, Skin Cells, Liver Cells, Skeletal & Muscle Cells, Renal Cells, Heart Cells, and Others. By Type the market has been segmented into Human Primary Cells and Animal Primary Cells. By Application the market has been segmented into Stem Cell Therapy, Virology, Cancer Research, Tissue Replacement, and 3D Cell Culture. By End-user the market has been segmented into Pharmaceutical & Biotechnology Companies, CROs, and Research Institutes.

List the key industry players of the Primary Cells market?

ZenBio, Thermo Fisher Scientific, STEMCELL Technologies, PromoCell, Merck KGaA, Inventia Life Science, Lonza, Cell Biologics, Inc., Axol Biosciences Ltd., American Type Culture Collection, and AllCells.

Which region is more appealing for vendors employed in the Primary Cells market?

North America is expected to account for the highest revenue share with 35%, and boasting an impressive market value of USD 55.5 Billion. Therefore, the Primary Cells industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for Primary Cells?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the Primary Cells Market.

Primary Cells Market By Source (Hematopoietic Cells, Lung Cells, Gastrointestinal Cells, Skin Cells, Liver Cells, Skeletal & Muscle Cells, Renal Cells, Heart Cells, and Others), By Type (Human Primary Cells and Animal Primary Cells), By Application (Stem Cell Therapy, Virology, Cancer Research, Tissue Replacement, and 3D Cell Culture), By End-user (Pharmaceutical & Biotechnology Companies, CROs, and Research Institutes), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Oct 2024
Report ID: 125920
Number of Pages: 234
Format:

- ZenBio
- Thermo Fisher Scientific Company Profile
- STEMCELL Technologies
- PromoCell
- Merck KGaA Company Profile
- Inventia Life Science
- Lonza Group AG Company Profile
- Cell Biologics, Inc.
- Axol Biosciences Ltd.
- American Type Culture Collection
- AllCells
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 125920
Published Date Oct 2024
Rating
- ★★★★★
  
  ★★★★★
- (86)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)